|
Manuel Zorzi describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo The impact on colorectal cancer mortality of screening with fecal immunochemical test takes place earlier and is more pronounced than with the guaiac test. SCREENING PROGRAMS WITH FECAL IMMUNOCHEMICAL TEST REDUCE COLORECTAL CANCER MORTALITY We compared colorectal cancer mortality of areas with and without a screening program based on the fecal immunochemical test. Before screening onset incidence and mortality rates were similar. Over 10 years with screening, mortality rates declined by 22% compared to other areas, from 45.7 to 36.2 x 100.000. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación Registro Tumori del Veneto - Sistema Epidemiologico Regionale, Padova, PD, Italy  Authors' Report Crónica del Autor Disminución de la mortalidad asociada con el carcinoma colorrectal con programas de detección sistemática Comparamos la mortalidad asociada con el carcinoma colorrectal en regiones en las cuales se aplicaba o no se aplicaba un programa de detección sistemática mediante una prueba de inmunohistoquímica fecal. Los índices de mortalidad previos al inicio del programa fueron similares en ambas regiones. Durante 10 años de detección sistemática, los índices de mortalidad disminuyeron un 22% en comparación con otras regiones, desde 45.7 hasta 36.2 x 100.000. Crónica del Autor Imprimir nota Referencias bibliográficas 1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-92, 2007. 2. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103:1541-9, 2008. 3. Hol L, Wilschut JA, Van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 100:1103-10, 209. 4. Zorzi M, et al. Incidence trends of colorectal cancer in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening. Epidemiol Prev 39(3) Suppl 1:115-25, 2015. 5. Costantini AS, Martini A, Puliti D, et al. Colorectal cancer mortality in two areas of Tuscany with different screening exposures. J Natl Cancer Inst 100:1818-21, 2008. 6. Hassan C, Rossi PG, Camilloni L, et al. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther 36:929-40, 2012. 7. Zorzi M, et al. Screening for colorectal cancer in Italy: 2011-2012 survey. Epidemiol Prev 39(3) Suppl 1:93-107, 2015. 8. Zorzi M, et al. Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening. Epidemiol Prev 39(3) Suppl 1:108-14, 2015. 9. Fedeli U, Zorzi M, Urso ED, Gennaro N, Dei Tos AP, Saugo M. Impact of fecal immunochemical test-based screening programs on proximal and distal colorectal cancer surgery rates: A natural multiple-baseline experiment. Cancer. doi: 10.1002/cncr.29623, 2015. Other articles written by the author Manuel Zorzi Otros artículos de Manuel Zorzi Zorzi M, Senore C, Turrin A, Mantellini P, Visioli CB, Naldoni C, Sassoli De' Bianchi P, Fedato C, Anghinoni E, Zappa M, Hassan C; Italian colorectal cancer screening survey group. Appropriateness of endoscopic surveillance in organized screening programmes based on the faecal immunochemical test. Gut pii: gutjnl-2015-310139, 20015. Zorzi M, Da Re F, Mantellini P, Naldoni C, Sassoli de' Bianchi P, Senore C, Turrin A, Visioli CB, Zappa M and the Italian colorectal cancer screening survey group. Screening for colorectal cancer in Italy: 2011-2012 survey. Epidemiol Prev 39(3) Suppl 1:93-107, 2015. Turrin A, Zorzi M, Rossi PG, Senore C, Campari C, Fedato C, Naldoni C, Anghinoni E, Carrozzi G, Bianchi PS, Zappa M; Italian colorectal cancer screening survey group. Colorectal cancer screening of immigrants to Italy. Figures from the 2013 National Survey. Prev Med, 2015; pii: S0091-7435(15)00268-6. doi: 10.1016/j.ypmed.2015.08.016. Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M; the Equipe Working Group. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut 2014; pii: gutjnl-2014-307954. doi: 10.1136/gutjnl-2014-307954. Zorzi M, Fedato C, Grazzini G, Stocco CF, Banovich F, Bortoli A, Cazzola L, Montaguti A, Moretto T, Zappa M and Vettorazzi M. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 60:944-9, 2011. Bergeron C, Giorgi-Rossi P, Cas F, Schiboni ML, Ghiringhello B, Dalla Palma P, Minucci D, Rosso S, Zorzi M, Naldoni C, Segnan N, Confortini M, Ronco G. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial. JNCI 107(12), 2015: dju423. doi: 10.1093/jnci/dju423 Carozzi F, Gillio-Tos A, Confortini M, Del Mistro A, Sani C, De Marco L, Girlando S, Rosso S, Naldoni C, Palma PD, Zorzi M, Giorgi-Rossi P, Segnan N, Cuzick J, Ronco G; the NTCC working group. Risk of high grade CIN on follow up in HPV positive women according to baseline p16-INK4A results: prospective analysis of a sub-study nested in a randomised controlled trial. Lancet Oncol 14(2):168-76, 2013. Zorzi M, Del Mistro A, Farruggio A, De' Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon M, Cogo C, Ferro A. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. BJOG 1260-8, 2013. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro AR, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J, and the New Technologies for Cervical Cancer screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11(3):249-57, 2010. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro AR, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N and the New Technologies for Cervical Cancer screening (NTCC) Working Group. Results at recruitment from a randomised controlled trial comparing Human Papillomavirus testing alone to conventional cytology as the primary cervical cancer screening test. JNCI 100:492-501, 2008. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo Impact on Colorectal Cancer Mortality of Screening Programmes Based on the Faecal Immunochemical Test Author / Autor Manuel Zorzi1, Ugo Fedeli2, Mario Saugo3, Angelo Paolo Dei Tos4 4 Director, Registro Tumori del Veneto, Padova Dipartimento Di Anatomia Patologica, Ospedale Santa Maria Di Ca’ Foncello, Treviso, Italia, Director Access to the original source Gut URL of Abstract page in Medline: / URL del abstract en Medline: http://www.ncbi.nlm.nih.gov/pubmed/25179811 siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
